Biopolym. Cell. 1996; 12(1):5-15.
Characteristic features of specific fermentative function of thrombin and it's connection with the structure
1Sereyskaya A. A.
  1. Institute of Bioorganic Chemistry and Petrochemistry, NAS of Ukraine
    1, Murmans'ka Str., Kyiv, Ukraine, 02094


This review deals with thrombin peculiarities responsible for its highly selective and effective action in blood clotting system Role of enzyme additional binding-recognition exosites in interaction with fibrinogen is analyzed. As a result of thrombin-fibrinogen recognition complex formation is supposed some conformational changes to arise that couple exosite with active centre and accelerate the catalytic process.


[1] Hartley BS. The active centers of serine proteinases. Ann N Y Acad Sci. 1974;227:438-45.
[2] Izquierdo C, Burguillo FJ. Synthetic substrates for thrombin. Int J Biochem. 1989;21(6):579-92.
[3] Serebryanyy SB. Thrombin, its structure and features of catalysis.. Biokhimiya i fiziologiya zhivotnykh i cheloveka. 1982;6: 14-26.
[4] Sereyskaya AA, Karabut LV, Shchechkin IE. On the efficiency and selectivity of thrombin catalysis. Thromb Res. 1994;74(5):549-50.
[5] Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 1989;8(11):3467-75.
[6] Stubbs MT, Oschkinat H, Mayr I, Huber R, Angliker H, Stone SR, Bode W. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem. 1992;206(1):187-95.
[7] Martin PD, Robertson W, Turk D, Huber R, Bode W, Edwards BF. The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution. J Biol Chem. 1992;267(11):7911-20.
[8] Sereiskaya AA, Karabut LV, Smirnova IV, Shchechkin IE. Interaction of additional center of thrombin with a complementary site of fibrinogene. Doklady Akad Nauk Ukr SSR. 1991; (11):140-3.
[9] Karabut LV, Sereyskaya AA. The peculiarities of thrombin binding sites structure. Putative mechanisms of interaction with highmolecular and small substrates. Biopolym Cell. 1992; 8(5):31-5.
[10] Karabut LV, Shchechkin IE, Serejskaya AA. Modelling of thrombin-fibrinogen recognition complex. Biopolym Cell. 1994; 10(6):83-7.
[11] Tsukada H, Blow DM. Structure of alpha-chymotrypsin refined at 1.68 A resolution. J Mol Biol. 1985;184(4):703-11.
[12] Kibirev VK, Sereyskaya AA. Structural bases of thrombin specificity. Biokhimiya zhivotnykh i cheloveka.. 1989; 13: 10-18.
[13] Chang JY. Thrombin specificity. Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate. Eur J Biochem. 1985;151(2):217-24.
[14] Banner DW, Hadv?ry P. Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. J Biol Chem. 1991;266(30):20085-93.
[15] Bode W, Turk D, St?rzebecher J. Geometry of binding of the benzamidine- and arginine-based inhibitors N alpha-(2-naphthyl-sulphonyl-glycyl)-DL-p-amidinophenylalanyl-pipe ridine (NAPAP) and (2R,4R)-4-methyl-1-[N alpha-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulphonyl)-L-arginyl]-2-piperidine carboxylic acid (MQPA) to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin. Eur J Biochem. 1990;193(1):175-82.
[16] Poiarkova SA, Kibirev VK, Serebriany? SB. Inhibitory effect of methyl esters of arginine-containing oligopeptides on thrombin and trypsin. Ukr Biokhim Zh. 1987;59(5):5-11.
[17] Poiarkova SA, Kibirev NK, Serebriany? SB. Inhibition of the proteolytic activity of thrombin by methyl esters of arginine-containing oligopeptides. Ukr Biokhim Zh. 1986;58(6):3-8.
[18] Magnusson S, Petersen TE. Proteases a. biological control. Conf. on cell proliferation: Abstr. New York: Cold Spring Harbor Lab., 1975;2: 123-49.
[19] Sereyskaya AA. On thrombin supespecificity. Molekulyarnaya biologiya (Kiev). 1980; 27: 68-79.
[20] Fenton JW 2nd. Thrombin specificity. Ann N Y Acad Sci. 1981;370:468-95.
[21] Karshikov A, Bode W. Electrostatic properties of thrombin: importance for structural stabilization and ligand binding. Semin Thromb Hemost. 1993;19(4):334-43.
[22] Fenton JW 2nd, Olson TA, Zabinski MP, Wilner GD. Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition. Biochemistry. 1988;27(18):7106-12.
[23] Whinna HC, Church FC. Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor. J Protein Chem. 1993;12(6):677-88.
[24] Seegers WH, Hassouna H, Walz G. et al. Prothrombin and thrombin. Selected aspects of thrombin formation, properties, inhibition and immunology. Sem Thromb Hemost. 1975; 1(3):211-83.
[25] Hofsteenge J, Braun PJ, Stone SR. Enzymatic properties of proteolytic derivatives of human alpha-thrombin. Biochemistry. 1988;27(6):2144-51.
[26] Henriksen RA, Mann KG. Identification of the primary structural defect in the dysthrombin thrombin Quick I: substitution of cysteine for arginine-382. Biochemistry. 1988;27(26):9160-5.
[27] Hogg DH, Blomb?ck B. The mechanism of the fibrinogen-thrombin reaction. Thromb Res. 1978;12(6):953-64.
[28] Scheraga HA. Chemical basis of thrombin interactions with fibrinogen. Ann N Y Acad Sci. 1986;485:124-33.
[29] Sere?skaia AA, Smirnova IV, Karabut LV, Chetyrkina SN. The critical role of the interaction of anion-binding thrombin exosite with complementary segment of the Aalpha-chain of fibrinogen in detecting high specificity of the enzyme. Biokhimiia. 1994;59(3):360-7.
[30] Binnie CG, Lord ST. A synthetic analog of fibrinogen alpha 27-50 is an inhibitor of thrombin. Thromb Haemost. 1991;65(2):165-8.
[31] Maraganore JM, Bourdon P, Jablonski J, Ramachandran KL, Fenton JW 2nd. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry. 1990;29(30):7095-101.
[32] Hopfner KP, Ayala Y, Szewczuk Z, Konishi Y, Di Cera E. Chemical compensation in macromolecular bridge-binding to thrombin. Biochemistry. 1993;32(12):2947-53.
[33] Rydel TJ, Tulinsky A, Bode W, Huber R. Refined structure of the hirudin-thrombin complex. J Mol Biol. 1991;221(2):583-601.
[34] Parry MA, Stone SR, Hofsteenge J, Jackman MP. Evidence for common structural changes in thrombin induced by active-site or exosite binding. Biochem J. 1993;290 ( Pt 3):665-70.
[35] Mathews II, Padmanabhan KP, Ganesh V, Tulinsky A, Ishii M, Chen J, Turck CW, Coughlin SR, Fenton JW 2nd. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Biochemistry. 1994;33(11):3266-79.
[36] Church FC, Lundblad RL, Noyes CM. Modification of histidines in human prothrombin. Effect on the interaction of fibrinogen with thrombin from diethyl pyrocarbonate-modified prothrombin. J Biol Chem. 1985;260(8):4936-40.
[37] Lundblad RL, Noyes CM, Featherstone GL, Harrison JH, Jenzano JW. The reaction of bovine alpha-thrombin with tetranitromethane. Characterization of the modified protein. J Biol Chem. 1988;263(8):3729-34.
[38] Le Bonniec BF, Guinto ER, MacGillivray RT, Stone SR, Esmon CT. The role of thrombin's Tyr-Pro-Pro-Trp motif in the interaction with fibrinogen, thrombomodulin, protein C, antithrombin III, and the Kunitz inhibitors. J Biol Chem. 1993;268(25):19055-61.
[39] Dufton MJ. Could domain movements be involved in the mechanism of trypsin-like serine proteases? FEBS Lett. 1990;271(1-2):9-13.